FDA Mandates Liver Testing for Fezolinetant Prescribing
The Food and Drug Administration mandates specific hepatic laboratory monitoring for patients prescribed fezolinetant to manage vasomotor symptoms of menopause. This nonhormonal therapy operates via a single fixed oral dose ... Read More